JHBP (CY) Holdings Limited
嘉和生物藥業 (開曼) 控股有限公司

07 OCT 2020

JHBP (CY) Holdings Limited (the “Company”) is a commercial-ready biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. The Company has strategically focused on major therapeutic areas with substantial unmet medical needs. At present, the Company has 15 drug candidates, 11 of which have entered the clinical development stage or at IND stage.

嘉和生物藥業（開曼）控股有限公司（「公司」）是一家正在進入商業化階段的生物製藥公司，專注於腫瘤及自身免疫藥物的研發。公司的戰略重點一直側重於有大量未滿足醫療需求的主要治療領域。目前，公司擁有15種候選藥物，其中11種已進入臨床開發階段或處於IND階段。